Acadian Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.86M | Sell |
|
|||||
|
2025
Q2 | $5.14M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $85K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.46M | Sell |
|
|||||
|
2020
Q4 | $6.05M | Hold |
|
|||||
|
2020
Q3 | $3.99M | Sell |
|
|||||
|
2020
Q2 | $5.83M | Sell |
|
|||||
|
2020
Q1 | $8.31M | Sell |
|
|||||
|
2019
Q4 | $21.6M | Sell |
|
|||||
|
2019
Q3 | $23.6M | Sell |
|
|||||
|
2019
Q2 | $36.1M | Sell |
|
|||||
|
2019
Q1 | $50M | Sell |
|
|||||
|
2018
Q4 | $54.1M | Sell |
|
|||||
|
2018
Q3 | $110M | Buy |
|
|||||
|
2018
Q2 | $87M | Sell |
|
|||||
|
2018
Q1 | $70.4M | Buy |
|
|||||
|
2017
Q4 | $75.7M | Buy |
|
|||||
|
2017
Q3 | $67.4M | Buy |
|
|||||
|
2017
Q2 | $39.4M | Sell |
|
|||||
|
2017
Q1 | $34.2M | Sell |
|
|||||
|
2016
Q4 | $32.2M | Sell |
|
|||||
|
2016
Q3 | $57.2M | Buy |
|
|||||
|
2016
Q2 | $13.5M | Buy |
|
|||||
|
2016
Q1 | $6.27M | Buy |
|
|||||
|
2015
Q4 | $6.93M | Buy |
|
|||||
|
2015
Q3 | $16K | Sell |
|
|||||
|
2015
Q2 | $19K | Buy |
|
|||||
|
2015
Q1 | $12K | Hold |
|
|||||
|
2014
Q4 | $11K | Sell |
|
|||||
|
2014
Q3 | $7.85M | Sell |
|
|||||
|
2014
Q2 | $25M | Buy |
|
|||||
|
2014
Q1 | $81K | Sell |
|
|||||
|
2013
Q4 | $5.25M | Sell |
|
|||||
|
2013
Q3 | $13M | Buy |
|
|||||
|
2013
Q2 | $174K | Buy |
|